Filing Details
- Accession Number:
- 0001140361-12-039465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-05 16:12:36
- Reporting Period:
- 2012-08-31
- Filing Date:
- 2012-09-05
- Accepted Time:
- 2012-09-05 16:12:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1389046 | F James Polewaczyk | One Idexx Drive Westbrook ME 04092 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-31 | 2,500 | $34.37 | 8,501 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-31 | 1,201 | $56.95 | 9,702 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-31 | 1,755 | $56.95 | 11,457 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-31 | 3 | $34.37 | 11,460 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-31 | 5,459 | $95.01 | 6,001 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-08-31 | 2,500 | $0.00 | 2,500 | $34.37 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-08-31 | 1,201 | $0.00 | 1,201 | $56.95 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-08-31 | 1,755 | $0.00 | 1,755 | $56.95 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-08-31 | 3 | $0.00 | 3 | $34.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,337 | 2016-02-13 | No | 4 | M | Direct | |
| 1,200 | 2015-02-13 | No | 4 | M | Direct | |
| 1,755 | 2015-02-13 | No | 4 | M | Direct | |
| 2,910 | 2016-02-13 | No | 4 | M | Direct |
Footnotes
- Includes 79 shares and 51 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/30/2012 and 06/30/2012, respectively.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.00 to $95.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of options to buy shares of common stock becomes exercisable as to 4,149 on 02/14/2010, 02/14/2011, 04/14/2012, 02/14/2013, and the remaining 1,241 shares on 02/14/2014.
- Grant of options to buy shares of common stock becomes exercisable as to 1,201 shares on 02/14/2009, 02/14/2010, 02/14/2011, 02/14/2012, and the remaining 1,200 shares on 02/14/2013.
- Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.
- Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010, 02/14/2011, 02/14/2012, 02/14/2013, and the remaining 2,909 shares on 02/14/2014.
Billionaire Hedge Funds
